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Bilitranslocase is a 38 kDa membrane protein [1] localised at
the vascular surface of the liver cells. The isolated protein is
endowed with transport function of sulphobromophthalein
(SBP), as directly demonstrated in reconstituted systems.
Thus, its proposed physiological role is to mediate the tra⁄c
of SBP and related organic anions across the sinusoidal do-
main of the hepatocyte plasma membrane. On account of the
known competition between SBP and bilirubin for the ¢rst
step of liver uptake observed in vivo, bilirubin had been
pointed out as the most obvious physiological substrate for
bilitranslocase. A strong indication in this sense has come with
the ¢nding, within bilitranslocase primary structure, of the
sequence EDSQGQHLSSF [2], which has the peculiarity of
being the central portion of a motif highly conserved in K-
phycocyanins, biliproteins found in cyanobacteria. Whereas
in K-phycocyanins this motif is involved in binding the pros-
thetic group phycocyanobilin [3], a compound structurally re-
lated to bilirubin, in bilitranslocase it has been shown to act as
the bilirubin-binding site [2]. Indeed, the a⁄nity of the carrier
for the pigment is high enough to ensure bilirubin extraction
from the blood stream (Kd of the complex = 2 nM) [2].
Antibodies raised against the sequence in question have
been employed in a tissue distribution study in the rat [4]
aimed at ¢nding the expression of proteins with the biliru-
bin-binding sequence in that organism. By these means and
somewhat unexpectedly, the sequence has been found in the
stomach mucosa, associated with a protein displaying an elec-
trophoretic mobility (38 kDa) identical to that of liver bili-
translocase. Immunohistochemical analysis has shown that
this protein is associated with di¡erent epithelial cell types
of the gastric mucosa.
A critical question therefore concerns the kind of evolution-
ary pressure that has resulted in the expression, at this level,
of a membrane protein endowed with high-a⁄nity bilirubin-
binding properties. Obviously, bilirubin in the food is not a
likely candidate for such an evolutionary function. In con-
trast, such a function could be envisaged for nicotinic acid,
in view of the fact that bilitranslocase binds this vitamin with
high a⁄nity (Kd of the complex = 11 nM) [3]. The possibility
could therefore be considered that the physiological role of
the sequence EDSQGQHLSSF is related to nicotinic acid ab-
sorption at the gastric level.
To test the hypothesis that, indeed, the protein present in
epithelial cells of the gastric mucosa could be an electrogenic
SBP carrier, like in the liver, the post-mitochondrial fraction
from gastric epithelia was tested for electrogenic SBP trans-
port. This substrate was indeed found to be taken up electro-
genically by the preparation, with the same kinetics observed
with analogous liver preparations (KM = about 5 WM). Anti-
sequence antibodies caused inhibition of electrogenic SBP up-
take and, in addition, this e¡ect could be lessened in a con-
centration-dependent manner by the presence of nicotinic
acid. The data obtained ¢tted the Scrutton and Utter equa-
tion, making it possible to calculate the dissociation constants
of the carrier^ligand complex. The value (Kd = 10.23 þ 0.32
nM) was, again, virtually identical to that obtained with liver
preparations [3]. Interestingly, when the vitamer nicotinamide
was tested in the same kind of inactivation analysis, no e¡ect
was found, reinforcing the early conclusion that the negative
charge on a substrate is a critical molecular requirement for
the interaction with bilitranslocase.
All these data make it possible to conclude that the 38 kDa,
antibody-reacting protein found in the gastric mucosa is a
carrier protein displaying the transport kinetic properties of
bilitranslocase. Moreover, it contains its bilirubin-binding se-
quence, which is the site of high-a⁄nity nicotinic acid binding,
too.
Since the epithelial cells of the gastric mucosa are equipped
with a SBP transport protein, it was expected that SBP could
be absorbed by the stomach. Data obtained in in vivo experi-
ments involving rats showed that SBP was absorbed rapidly
and extensively. In particular, the bimodal kinetics of SBP
disappearance suggested the involvement of two mechanisms
of absorption. A fast, exponential step, typical of carrier-
mediated processes, was more evident at low substrate con-
centrations, whereas a slow, linear one, describing passive
di¡usion, superimposed at the higher concentrations tested.
The decay constants obtained from the fast steps were com-
patible with a mechanism operating with a substrate a⁄nity in
the low micromolar concentration range.
The most direct approach to the study of the involvement
of bilitranslocase in nicotinic acid uptake by the gastric mu-
cosa would make use of the anti-sequence antibody. However,
under the physiological conditions of the gastric lumen, the
antigen^antibody reaction cannot occur, mainly because of
pH-dependent denaturation and the proteolytic action of pep-
sin. An experimental model employing the isolated stomach
was therefore set up, satisfying the following requirements:
(a) intact gastric mucosa; (b) favourable conditions for the
binding of the anti-sequence antibody to its target; and
(c) minimal humoral and cellular e¡ects following the immu-
nological reaction.
A large patch of the organ, comprising nearly the entire
corpus and antrum, was mounted on a two-chamber device,
thus delimiting a serosal and a mucosal compartment. Both
surfaces were in contact with a bu¡ered saline solution con-
taining glucose. Nicotinic acid was added in the mucosal com-
partment and its concentration was estimated by reversed-
phase HPLC. With time, the vitamin concentration in the
mucosal compartment was found to lessen. The vitamin was
not detected in the serosal compartment, indicating that,
under the prevailing experimental conditions, plain leakage
from one compartment to the other did not take place and
nicotinic acid was indeed accumulated in the preparation. The
e¡ect of anti-bilitranslocase antibodies on nicotinic acid dis-
appearance is shown in Fig. 1. Two curves were obtained by
¢tting the data to a single-exponential decay equation. As also
indicated by the decay constants ratio (kab/k0 = 0.15), a strong
inhibitory e¡ect of the anti-bilitranslocase antibody on nico-
tinic acid uptake was observed.
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These data show the carrier’s accessibility to the antibodies
added from the mucosal side, indicating that also in this organ
the carrier is expressed at the cell membrane level and, in
more detail, that the bilirubin-binding motif is exposed at
the outer surface of the cells, as expected for its proposed
function.
The most interesting outcome of this work is the demon-
stration that nicotinic acid can be taken up at the gastric level
via a mechanism involving bilitranslocase. The function envis-
aged for this carrier in the stomach seems to be a real evolu-
tionary advantage, accounting for the maintenance of its ex-
pression at the gastric level, since it enables the organism to
extract quite minute amounts of nicotinic acid from the food
as early as possible during digestion. It may be useful to
remember in this context that gastric absorption of nicotinic
acid is described both in humans [5] and in other ruminants
and bilitranslocase therefore stands as the molecular mecha-
nism ¢tting this role. Absorption at the level of the small
intestine would involve substantially higher concentrations
of nicotinic acid, set free during the digestion process. The
mechanisms proposed are both passive di¡usion driven by
post-absorptive metabolism and carrier-mediated transport.
The latter consists in two low-a⁄nity carriers, i.e. MCT1, a
monocarboxylate^proton co-transporter and AE2, a mono-
carboxylate^bicarbonate antiporter. Both of these systems dis-
play apparent KM values in the millimolar range.
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Fig. 1. The e¡ect of the anti-bilitranslocase antibody on nicotinic
acid absorption by the isolated rat stomach. Isolated rat stomach
patches consisting of the entire surface of the antrum and the cor-
pus were mounted onto a two-chamber device. The serosal compart-
ment consisted of 3 ml of a bu¡ered saline solution (5.55 mM glu-
cose, 115 mM NaCl, 8 mM KCl, 1.25 mM CaCl2, 1.20 mM MgCl2,
2 mM KH2PO4, 25 mM Tris^HCl pH 7.4). The mucosal surface
was pre-incubated at 37‡C in 1 ml 0.1 M Tris pH 7.4, 1% (w/v) bo-
vine serum albumin, 5.44 mM glucose without (open symbols) and
with (closed symbols) anti-bilitranslocase antibody (96.5 Wg IgG).
After 10 min, the tube holding the stomach patch was transferred
into a vial with 8.5 ml 40 WM nicotinic acid in the bu¡ered saline
solution mentioned above. Samples were withdrawn at the indicated
times and analysed by HPLC: 20 Wl sample was injected into a re-
versed phase column (Ultrasphere ODS, 5 Wm particles, 4.6
mmU15 cm, Beckman Instruments Inc, San Ramon, CA, USA)
and eluted isocratically with 5 mM potassium phosphate bu¡er pH
6.8/acetonitrile (97:3, v/v). The £ow rate was 0.8 ml/min and the
elution was monitored at V= 260 nm. Under these conditions, at
room temperature, nicotinic acid eluted with a retention time
around 3 min (typically 2.9). Each type of symbol refers to a single
animal. Data were ¢tted to the single-exponential decay equation.
The following decay constants were found: k0 = 0.700 þ 0.08 min31
(n = 3) and kab = 0.109 þ 0.013 min31 (n = 3).
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